for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Alligator Bioscience AB

ATORX.ST

Latest Trade

12.74SEK

Change

0.20(+1.59%)

Volume

99,017

Today's Range

12.52

 - 

13.14

52 Week Range

10.60

 - 

27.40

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Alligator Bioscience Q3 Operating Loss Widens To Sek 58.5 Mln

Oct 24 (Reuters) - Alligator Bioscience AB <ATORX.ST>::INTERIM REPORT JANUARY-SEPTEMBER 2019.JULY-SEPTEMBER 2019 NET SALES, SEK 4.3 MILLION (0.2).JULY-SEPTEMBER 2019 OPERATING RESULT SEK -58.5 MILLION (-39.9).

Alligator Bioscience April-June Operating Loss At SEK 50.5 Mln

July 11 (Reuters) - Alligator Bioscience AB <ATORX.ST>::(PUBL) INTERIM REPORT JANUARY-JUNE 2019.APRIL-JUNE NET SALES, SEK 0.0 MILLION.APRIL-JUNE OPERATING LOSS SEK 50.5 MILLION.

Alligator Bioscience Q4 Net Sales Fall To SEK 25.6 Million

Feb 14 (Reuters) - Alligator Bioscience AB <ATORX.ST>::Q4 NET SALES SEK 25.6 MILLION VERSUS SEK 51.3 MILLION YEAR AGO.Q4 OPERATING RESULT, SEK -30.1 MILLION (10.7).

Alligator Bioscience Will Receive $3.5 Mln Under Agreement With Abclon

Nov 7 (Reuters) - Alligator Bioscience AB <ATORX.ST>::ALLIGATOR BIOSCIENCE TO RECEIVE MILLION-DOLLAR PAYMENTS - ABCLON PARTNER EXERCISES OPTION.WILL RECEIVE PAYMENTS OF MORE THAN USD 3.5 MILLION UNDER ITS COLLABORATION AGREEMENT WITH SOUTH KOREAN COMPANY ABCLON.PAYMENTS FOLLOWING EXERCISING OF AN OPTION BY HENLIUS , TO EXPAND FROM A REGIONAL TO A GLOBAL AGREEMENT.

Alligator Bioscience Q3 Net Sales Sek 0.2 Million

Oct 26 (Reuters) - Alligator Bioscience AB <ATORX.ST>::Q3 NET SALES SEK 0.2 MILLION VERSUS SEK 1.8 MILLION YEAR AGO.Q3 OPERATING LOSS SEK 39.9 MILLION VERSUS LOSS SEK 24.5 MILLION YEAR AGO.

Alligator Bioscience Submits Application For ATOR-1015 Phase I Study

July 19 (Reuters) - ALLIGATOR BIOSCIENCE AB <ATORX.ST>::HAS SUBMITTED CLINICAL TRIAL AUTHORIZATION (CTA) APPLICATION TO START PHASE I STUDY OF DRUG CANDIDATE ATOR-1015.

Alligator Bioscience Q2 Operating Loss Widens To SEK 39.1 Mln

July 12 (Reuters) - Alligator Bioscience AB <ATORX.ST>::APRIL-JUNE NET SALES, SEK 0.4 MILLION (1.3).APRIL-JUNE OPERATING RESULT, SEK -39.1 MILLION (-29.5).

Alligator Bioscience Q1 Operating Loss Widens To SEK 44.0 Million

April 26 (Reuters) - ALLIGATOR BIOSCIENCE AB <ATORX.ST>::Q1 NET SALES SEK 776,000 VERSUS SEK 2.5 MILLION YEAR AGO.Q1 OPERATING LOSS SEK 44.0 MILLION VERSUS LOSS SEK 19.1 MILLION YEAR AGO.

Alligator Bioscience AB Oct-Dec Net Sales, SEK 51.3 Million

Feb 16 (Reuters) - ALLIGATOR BIOSCIENCE AB <ATORX.ST>::OCT-DEC NET SALES, SEK 51.3 MILLION (6.4).OCT-DEC OPERATING RESULT, SEK 10.7 MILLION (-22.1).

Alligator Bioscience Contracts Theradex Oncology As Clinical CRO

Jan 25 (Reuters) - ALLIGATOR BIOSCIENCE AB <ATORX.ST>::ALLIGATOR BIOSCIENCE CONTRACTS THERADEX ONCOLOGY AS CLINICAL CRO FOR THE UPCOMING ATOR-1015 PHASE I STUDY.STUDY IS EXPECTED TO COMMENCE IN SECOND HALF OF 2018.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up